The latest research and expert insights about stimulants, opioids, and recovery issues.
Opioid Use Disorder, COVID-19, and HIV: Q&A with Leigh Mathias
For healthcare providers who treat people with HIV and/or substance misuse, the pandemic has created huge challenges. We recently sat down with one of our experts, Leigh J. Mathias, MPH, to understand the issues and where healthcare systems can go from here.
Are Syringe Programs the Secret to Addressing HIV and OUD?
Decades of research show that Syringe Service Programs (SSPs) are effective in reducing transmission of HIV and Hepatitis C virus, as well as increasing access to care for individuals who need medical and behavioral health services. Abt’s Niki Reddy unpacks what the research says.
Buprenorphine is an evidence-based treatment that helps patients with OUD. When used in HIV care settings, buprenorphine can support both OUD recovery and adherence to HIV medications, improving health outcomes for both OUD and HIV. Learn more about an innovative and effective clinical care model.
Clinical Coordinators and Medication for Opioid Use Disorder: Keys to Success?
Clinical coordinators play an essential role in linking patients to and retaining patients in medication therapy for opioid use disorder (OUD). In this webinar, panelists discussed the role of the clinical coordinator within the Dissemination of Evidence-Informed Interventions (DEII) initiative and lessons learned from the initiative that could be applied within the Ryan White HIV/AIDS Program community.
Click here to sign up for our bimonthly newsletter, which includes information about our work, staff, and current job openings, and other periodic mailings from Abt.
